BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  ORYZON to Provide Corporate Progress Updates at Several Events in January-February

  January 13, 2025

   · 

  8 min read
• Press Releases

  4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path

  January 13, 2025

   · 

  8 min read
• Press Releases

  4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway

  January 13, 2025

   · 

  9 min read
• Press Releases

  Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

  January 13, 2025

   · 

  5 min read
• Press Releases

  Y-mAbs Provides Strategic Business Update and 2025 Priorities

  January 13, 2025

   · 

  10 min read
• Press Releases

  BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)

  January 13, 2025

   · 

  8 min read
• Press Releases

  Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference

  January 13, 2025

   · 

  22 min read
• Press Releases

  Walden Biosciences Highlights 2024 Accomplishments and 2025 Priorities

  January 13, 2025

   · 

  4 min read
• Press Releases

  iTeos Announces 2025 Strategic Priorities and Anticipated Milestones

  January 13, 2025

   · 

  9 min read
• Press Releases

  Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update

  January 13, 2025

   · 

  8 min read